Literature DB >> 11510623

General anaesthesia for supratentorial neurosurgery.

P Ravussin1, O Wilder-Smith.   

Abstract

Anaesthesia for the surgical treatment of supratentorial tumours requires an understanding of: the pathophysiology of a localised or generalised increase in intracranial pressure (ICP), the regulation and maintenance of intracerebral perfusion, avoidance of secondary systemic insults to the brain, and the effects of anaesthetic drugs on ICP, cerebral perfusion and cerebral metabolism. Knowledge of the therapeutic options available for decreasing ICP, brain bulk and brain tension perioperatively is also essential. Potential complications which may present during supratentorial neurosurgery include massive intraoperative haemorrhage and seizures. The fact that the surgeon is operating on a tensed brain is also a potential source of difficulty. The need to monitor brain function and environment during surgery poses a challenge to the anaesthesiologist, as does the achievement of rapid emergence from anaesthesia with the adequate use of anaesthetic drugs.

Entities:  

Mesh:

Year:  2001        PMID: 11510623     DOI: 10.2165/00023210-200115070-00003

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  61 in total

1.  Induction of anaesthesia with propofol using a target-controlled infusion system.

Authors:  S Chaudhri; M White; G N Kenny
Journal:  Anaesthesia       Date:  1992-07       Impact factor: 6.955

2.  Effects of d-tubocurarine on intracranial pressure and thalamic electrical impedance.

Authors:  L Tarkkanen; L Laitinen; G Johansson
Journal:  Anesthesiology       Date:  1974-03       Impact factor: 7.892

3.  Effects of isoflurane on intraventricular pressure in neurosurgical patients.

Authors:  J J Gómez Sainz; J A Eléxpuru Camiruaga; F Fernández Cano; J L de la Herrán
Journal:  Br J Anaesth       Date:  1988-09       Impact factor: 9.166

Review 4.  Total intravenous anesthesia is best for neurological surgery.

Authors:  P Ravussin; N de Tribolet; O H Wilder-Smith
Journal:  J Neurosurg Anesthesiol       Date:  1994-10       Impact factor: 3.956

5.  A comparison of the cerebrovascular and metabolic effects of halothane and isoflurane in the cat.

Authors:  M M Todd; J C Drummond
Journal:  Anesthesiology       Date:  1984-04       Impact factor: 7.892

6.  Effects of nitrous oxide on cerebral haemodynamics and metabolism during isoflurane anaesthesia in man.

Authors:  L Algotsson; K Messeter; I Rosén; T Holmin
Journal:  Acta Anaesthesiol Scand       Date:  1992-01       Impact factor: 2.105

7.  The effects of dextrose infusion and head position on neurologic outcome after complete cerebral ischemia in primates: examination of a model.

Authors:  W L Lanier; K J Stangland; B W Scheithauer; J H Milde; J D Michenfelder
Journal:  Anesthesiology       Date:  1987-01       Impact factor: 7.892

8.  The effect of nitrous oxide on cortical cerebral blood flow during anesthesia with halothane and isoflurane, with and without morphine, in the rabbit.

Authors:  J C Drummond; M S Scheller; M M Todd
Journal:  Anesth Analg       Date:  1987-11       Impact factor: 5.108

9.  Cerebrovascular responsiveness to carbon dioxide in dogs with 1.4% and 2.8% isoflurane.

Authors:  R W McPherson; J E Briar; R J Traystman
Journal:  Anesthesiology       Date:  1989-05       Impact factor: 7.892

10.  The responsiveness of cerebral blood flow to changes in arterial carbon dioxide is maintained during propofol-nitrous oxide anesthesia in humans.

Authors:  J Fox; A W Gelb; J Enns; J M Murkin; J K Farrar; P H Manninen
Journal:  Anesthesiology       Date:  1992-09       Impact factor: 7.892

View more
  1 in total

1.  Acquisition of sensorimotor fMRI under general anaesthesia: Assessment of feasibility, the BOLD response and clinical utility.

Authors:  Adam Kenji Yamamoto; Joerg Magerkurth; Laura Mancini; Mark J White; Anna Miserocchi; Andrew W McEvoy; Ian Appleby; Caroline Micallef; John S Thornton; Cathy J Price; Nikolaus Weiskopf; Tarek A Yousry
Journal:  Neuroimage Clin       Date:  2019-07-02       Impact factor: 4.881

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.